Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
作者信息
Roncon Loris, Zuin Marco, Rigatelli Gianluca
机构信息
Department of Cardiology, Santa Maria Della Misericordia Hospital, Rovigo General Hospital, Viale tre Martiri, 45100, Rovigo, Italy.
School of Medicine, University of Ferrara, Ferrara, Italy.
出版信息
Intern Emerg Med. 2021 Mar;16(2):517-518. doi: 10.1007/s11739-020-02358-4. Epub 2020 May 6.
Abstract
摘要
相似文献
1
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.在感染新型冠状病毒2的住院患者中从口服抗凝剂转换为胃肠外肝素：评论
Intern Emerg Med. 2021 Mar;16(2):517-518. doi: 10.1007/s11739-020-02358-4. Epub 2020 May 6.
2
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.新型冠状病毒肺炎住院患者从口服抗凝剂转换为胃肠外给予肝素：评论
Intern Emerg Med. 2021 Mar;16(2):519-520. doi: 10.1007/s11739-020-02373-5. Epub 2020 May 21.
3
A Ghana-UK haematology "heparin" partnership.加纳与英国血液学领域的“肝素”合作关系。
Br J Haematol. 2020 Nov;191(3):e96-e97. doi: 10.1111/bjh.17048. Epub 2020 Aug 15.
4
Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.新型冠状病毒肺炎患者使用肝素进行治疗性抗凝。回复。
N Engl J Med. 2021 Nov 18;385(21):2014. doi: 10.1056/NEJMc2115560.
5
In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d.在因 COVID-19 住院的患者中，治疗剂量与预防剂量的肝素并未降低 28 天的复合结局。
Ann Intern Med. 2022 Feb;175(2):JC16. doi: 10.7326/J21-0020. Epub 2022 Feb 1.
6
Heparin-induced hyponatremia in COVID-19: A latent culprit!新冠病毒感染中肝素诱导的低钠血症：一个潜在的罪魁祸首！
Indian J Pharmacol. 2021 Nov-Dec;53(6):515-516. doi: 10.4103/ijp.ijp_517_21.
7
In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d.在 COVID-19 高危住院患者中，治疗剂量肝素与标准剂量肝素相比，可降低 30 天内的血栓栓塞或死亡风险。
Ann Intern Med. 2022 Feb;175(2):JC17. doi: 10.7326/J21-0019. Epub 2022 Feb 1.
8
Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports.日本 COVID-19 重症患者接受未分级肝素治疗后出现自发性肌肉血肿：两例病例报告。
Intern Med. 2021 Nov 1;60(21):3503-3506. doi: 10.2169/internalmedicine.7422-21. Epub 2021 Aug 24.
9
Heparin - Messias or Verschlimmbesserung?肝素——救星还是越帮越忙？
J Thromb Haemost. 2021 Oct;19(10):2373-2382. doi: 10.1111/jth.15464. Epub 2021 Jul 29.
10
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.阿加曲班治疗1例2019冠状病毒病患者的肝素诱导的血小板减少症
J Thromb Thrombolysis. 2020 Nov;50(4):1012-1014. doi: 10.1007/s11239-020-02248-8. Epub 2020 Aug 11.
本文引用的文献
1
Injury measurements improve interpretation of thrombus formation data in the cremaster arteriole laser-induced injury model of thrombosis.损伤测量可改善CREST 激光诱导血栓形成模型中血栓形成数据的解释。
J Thromb Haemost. 2020 Nov;18(11):3078-3085. doi: 10.1111/jth.15059. Epub 2020 Oct 29.
2
"Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendation from the women's SSC of the ISTH": Response to comment from Kitchen et al.“产科粘弹性检测（血栓弹力图/旋转血栓弹力图）的系统评价及国际血栓与止血学会女性特殊情况委员会的建议”：对基钦等人评论的回应
J Thromb Haemost. 2020 Sep;18(9):2420-2422. doi: 10.1111/jth.15007.
3
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study.因 SARS-CoV-2 肺炎住院患者无症状深静脉血栓形成的患病率：一项横断面研究。
Intern Emerg Med. 2020 Nov;15(8):1425-1433. doi: 10.1007/s11739-020-02472-3. Epub 2020 Aug 25.
Zotero 插件